Natera Company Profile (NASDAQ:NTRA)

About Natera

Natera logoNatera, Inc. is a diagnostics company. The Company's product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening (Horizon) to determine carrier status for various severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening (PGS) and Spectrum Pre-implantation Genetic Diagnosis (PGD) to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization (IVF) cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father(s).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NTRA
  • CUSIP:
Key Metrics:
  • Previous Close: $9.78
  • 50 Day Moving Average: $9.99
  • 200 Day Moving Average: $10.63
  • 52-Week Range: $6.73 - $13.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.19
  • P/E Growth: 0.00
  • Market Cap: $512.30M
  • Outstanding Shares: 52,382,000
  • Beta: 2.57
  • Net Margins: -36.64%
  • Return on Equity: -48.24%
  • Return on Assets: -31.26%
  • Current Ratio: 2.21%
  • Quick Ratio: 2.12%
Additional Links:
Companies Related to Natera:

Analyst Ratings

Consensus Ratings for Natera (NASDAQ:NTRA) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.67 (90.87% upside)

Analysts' Ratings History for Natera (NASDAQ:NTRA)
DateFirmActionRatingPrice TargetDetails
1/30/2017Canaccord GenuityReiterated RatingBuyView Rating Details
11/10/2016Benchmark Co.Boost Price TargetBuy$16.00 -> $20.00View Rating Details
8/5/2016Morgan StanleySet Price TargetBuy$20.00View Rating Details
6/3/2016Cowen and CompanyReiterated RatingOutperform$17.00View Rating Details
3/11/2016Piper Jaffray CompaniesReiterated RatingOverweight$24.00 -> $22.00View Rating Details
3/9/2016Robert W. BairdLower Price TargetOutperform$18.00 -> $15.00View Rating Details
9/28/2015WedbushUpgradeNeutral -> Outperform$20.00View Rating Details
(Data available from 2/22/2015 forward)


Earnings History for Natera (NASDAQ:NTRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q316($0.55)($0.50)$48.14 million$53.89 millionViewListenView Earnings Details
8/4/2016Q216($0.48)($0.46)$50.64 million$52.00 millionViewListenView Earnings Details
5/10/2016Q116($0.46)($0.17)$48.17 million$61.90 millionViewListenView Earnings Details
3/8/2016Q415($0.64)($0.47)$45.26 million$52.90 millionViewListenView Earnings Details
11/12/2015Q315($0.46)($0.39)$43.08 million$44.90 millionViewListenView Earnings Details
8/12/2015($0.44)($0.40)$42.69 million$45.09 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Natera (NASDAQ:NTRA)
Current Year EPS Consensus Estimate: $-1.68 EPS
Next Year EPS Consensus Estimate: $-1.58 EPS


Dividend History for Natera (NASDAQ:NTRA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Natera (NASDAQ:NTRA)
Insider Ownership Percentage: 18.91%
Institutional Ownership Percentage: 61.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2017Herm RosenmanCFOSell1,849$11.87$21,947.63View SEC Filing  
12/22/2016Jonathan SheenaInsiderSell16,213$12.00$194,556.00View SEC Filing  
12/20/2016Jonathan SheenaInsiderSell1,087$12.00$13,044.00View SEC Filing  
12/13/2016Jonathan SheenaInsiderSell2,700$12.00$32,400.00View SEC Filing  
12/6/2016Herm RosenmanCFOSell1,828$11.83$21,625.24View SEC Filing  
12/5/2016Matthew RabinowitzCEOSell14,021$12.02$168,532.42View SEC Filing  
12/1/2016Matthew RabinowitzCEOSell56,072$12.01$673,424.72View SEC Filing  
11/28/2016Matthew RabinowitzCEOSell146,756$12.50$1,834,450.00View SEC Filing  
11/21/2016Jonathan SheenaInsiderSell32,505$12.00$390,060.00View SEC Filing  
11/3/2016Herm RosenmanCFOSell1,852$7.98$14,778.96View SEC Filing  
10/6/2016Herm RosenmanCFOSell1,773$11.53$20,442.69View SEC Filing  
10/5/2016Jonathan SheenaInsiderSell1,600$12.00$19,200.00View SEC Filing  
9/6/2016Herm RosenmanCFOSell1,822$10.21$18,602.62View SEC Filing  
8/2/2016Herm RosenmanCFOSell1,833$12.98$23,792.34View SEC Filing  
7/6/2016Herm RosenmanCFOSell1,824$12.10$22,070.40View SEC Filing  
7/1/2016Matthew RabinowitzCEOSell104,892$12.14$1,273,388.88View SEC Filing  
6/19/2016Jonathan SheenaCTOSell188,442$11.94$2,249,997.48View SEC Filing  
6/19/2016Matthew RabinowitzCEOSell732,831$11.94$8,750,002.14View SEC Filing  
6/19/2016Roelof BothaDirectorBuy837,521$11.94$10,000,000.74View SEC Filing  
6/2/2016Herm RosenmanCFOSell1,806$12.04$21,744.24View SEC Filing  
2/1/2016Jonathan SheenaCTOSell10,000$8.03$80,300.00View SEC Filing  
1/5/2016Matthew RabinowitzCEOSell54,683$10.37$567,062.71View SEC Filing  
1/4/2016Jonathan SheenaCTOSell25,000$10.06$251,500.00View SEC Filing  
12/31/2015Matthew RabinowitzCEOSell111,513$10.83$1,207,685.79View SEC Filing  
12/29/2015Jonathan SheenaCTOSell50,000$10.44$522,000.00View SEC Filing  
12/29/2015Matthew RabinowitzCEOSell83,804$10.62$889,998.48View SEC Filing  
7/8/2015James HealyDirectorBuy350,000$18.00$6,300,000.00View SEC Filing  
7/2/2015James HealyDirectorBuy400,000$22.81$9,124,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Natera (NASDAQ:NTRA)
News IconNatera Inc NTRA Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:NTRA) - February 20 at 9:46 AM
News IconStock Perspective: Natera Inc (NASDAQ:NTRA) Company Earnings Watch - Aiken Advocate (NASDAQ:NTRA) - February 14 at 1:06 AM
News IconHere's Who Just Picked Up Natera Inc. (NASDAQ:NTRA) Shares - Small Cap Exclusive (press release) (NASDAQ:NTRA) - February 10 at 1:02 AM logoNATERA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:NTRA) - February 8 at 7:48 PM logoNatera (NTRA) Names Mike Brophy as CFO (NASDAQ:NTRA) - February 4 at 12:42 AM logoNatera Inc. Announces Appointment of Mike Brophy as New Chief Financial Officer (NASDAQ:NTRA) - February 4 at 12:42 AM logoNatera (NTRA) Names Mike Brophy as CFO - (NASDAQ:NTRA) - February 3 at 7:40 PM
News IconInvestor Radar: Taking a Closer Look at Natera, Inc. (NASDAQ:NTRA) - The Tribune (NASDAQ:NTRA) - January 25 at 9:26 PM
News IconNatera Inc. (NTRA) stock slides, "Buy" rating reaffirmed by Canaccord Genuity Analysts - BNB Daily (blog) (NASDAQ:NTRA) - January 25 at 9:26 PM
News IconRSI Hits Crucial Level, Enters Oversold Range: Natera, Inc ... - Wall Street Beacon (NASDAQ:NTRA) - January 24 at 7:41 PM
News IconInvesting Focus: Indicators in View on Shares of Natera Inc (NTRA) - Rives Journal (NASDAQ:NTRA) - January 21 at 5:45 AM
News IconStock Momentum Skidding to a Halt For Natera, Inc. (NASDAQ:NTRA) - Wall Street Beacon (NASDAQ:NTRA) - January 18 at 12:17 AM logoNatera Announces Results From DNAFirst Study, Validating Use Of NIPT In Routine Prenatal Care (NASDAQ:NTRA) - January 17 at 11:26 AM logo8:06 am Natera announces results from the DNAFirst trial; showing that non-invasive prenatal screening tests can be effectively and appropriately offered as a primary screen for all pregnant women, regardless of risk due to maternal age or (NASDAQ:NTRA) - January 17 at 11:26 AM logoNatera, Inc. – Value Analysis (NASDAQ:NTRA) : January 13, 2017 (NASDAQ:NTRA) - January 13 at 11:34 PM
News IconWill The Needle Move For Natera Inc (NASDAQ:NTRA) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:NTRA) - January 13 at 5:37 AM logoNatera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : January 12, 2017 (NASDAQ:NTRA) - January 12 at 7:34 PM logo8:13 am Natera terminates a distribution agreement with Bio-reference Laboratories; intends to promote Panorama directly to clinicians, who previously ordered this test through Bio-Reference (NASDAQ:NTRA) - January 10 at 7:47 PM logoNatera Inc. Terminates NIPT Distribution Agreement with Bioreference Labs (NASDAQ:NTRA) - January 10 at 8:49 AM
News IconUpside Alert: Delving into Shares of Natera, Inc. (NASDAQ:NTRA) - Prospect Journal (NASDAQ:NTRA) - January 9 at 7:37 PM
News IconNatera Inc NTRA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:NTRA) - January 8 at 6:37 PM logoAnalyst Activity – Canaccord Genuity Initiates Coverage On Natera (NASDAQ:NTRA) With a Buy (NASDAQ:NTRA) - January 6 at 7:38 PM logoInsider Trading Activity Natera Inc. (NASDAQ:NTRA) – Insider Sold ... - Market Exclusive (NASDAQ:NTRA) - December 30 at 8:17 AM logoInsider Trading Activity Natera Inc. (NASDAQ:NTRA) – Insider Sold 16,213 shares of Stock (NASDAQ:NTRA) - December 28 at 10:00 AM logoInsider Trading Activity Natera Inc. (NASDAQ:NTRA) – Insider Sold 1,087 shares of Stock (NASDAQ:NTRA) - December 23 at 7:04 PM logoNatera : Provides Constellation™ Update (NASDAQ:NTRA) - December 22 at 8:05 AM logoNatera Provides Constellation™ Update (NASDAQ:NTRA) - December 21 at 10:08 AM
News IconAnalysts Projecting Upside, Can This Stock Surge Higher: Natera, Inc. (NASDAQ:NTRA) - Prospect Journal (NASDAQ:NTRA) - December 20 at 1:01 PM logoETFs with exposure to Natera, Inc. : December 19, 2016 (NASDAQ:NTRA) - December 20 at 1:01 PM
News IconChecking the Metrics on Shares of Natera, Inc. (NASDAQ:NTRA) - Marion Business Daily (NASDAQ:NTRA) - December 19 at 12:12 AM
News IconValue Composite Score Update on Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - December 17 at 7:22 PM
News IconTechnical Buzz on Natera, Inc. (NASDAQ:NTRA) - Marion Business Daily (NASDAQ:NTRA) - December 15 at 5:43 AM logoNatera Announces Participation In I-SPY 2 TRIAL For Breast Cancer (NASDAQ:NTRA) - December 14 at 7:37 PM
News IconInvestor Radar: Taking a Closer Look at Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - December 13 at 7:20 PM
News IconInvestor Monitor: Looking Closer at Shares of Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - December 12 at 9:58 AM
News IconTop Stock With Upside & Growth Potential: Natera, Inc. (NASDAQ:NTRA) - Prospect Journal (NASDAQ:NTRA) - December 6 at 9:40 AM
News IconWatching the Levels for Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - December 3 at 6:05 PM
News IconFCF Score Check on Shares of Natera, Inc. (NASDAQ:NTRA) - Marion Business Daily (NASDAQ:NTRA) - December 2 at 12:29 PM logoThe Centers For Medicare And Medicaid Services Establishes 2017 Pricing For Aneuploidy And Microdeletion Testing (NASDAQ:NTRA) - December 1 at 9:15 AM logoNatera CEO Sells Shares of Company - (NASDAQ:NTRA) - November 30 at 11:45 AM
News IconStock Tracker: Looking at the Numbers for Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - November 30 at 11:45 AM logoNatera CEO Sells Shares of Company (NASDAQ:NTRA) - November 30 at 11:45 AM
News IconMarket Scope: F-Score and Volatility Review for Natera, Inc. (NASDAQ:NTRA) - The Business Journal (NASDAQ:NTRA) - November 24 at 6:34 PM
News IconADX in View on Shares of Natera Inc (NTRA) - StockTalk Daily (NASDAQ:NTRA) - November 23 at 6:37 PM logoETFs with exposure to Natera, Inc. : November 23, 2016 (NASDAQ:NTRA) - November 23 at 6:37 PM
News IconEarnings According to Analysts for Natera Inc (NASDAQ:NTRA)? - CSZ News (NASDAQ:NTRA) - November 22 at 10:48 AM
News IconMA, RSI, and CCI Update on This Stock: Natera Inc (NTRA) - StockTalk Daily (NASDAQ:NTRA) - November 22 at 10:48 AM logoNatera to Present at the 28th Annual Piper Jaffray Health Conference (NASDAQ:NTRA) - November 22 at 10:48 AM logoNatera, Inc. :NTRA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016 (NASDAQ:NTRA) - November 21 at 11:47 AM
News IconTrading Watch: FCF and Piotroski Score Check for Natera, Inc. (NASDAQ:NTRA) - Wall Street Lion (NASDAQ:NTRA) - November 20 at 6:17 PM


What is Natera's stock symbol?

Natera trades on the NASDAQ under the ticker symbol "NTRA."

Where is Natera's stock going? Where will Natera's stock price be in 2017?

6 equities research analysts have issued 1 year price targets for Natera's shares. Their predictions range from $15.00 to $22.00. On average, they expect Natera's share price to reach $18.67 in the next year.

When will Natera announce their earnings?

Natera is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

Who owns Natera stock?

Natera's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Orbimed Advisors LLC (2.44%), Franklin Resources Inc. (1.99%), State Street Corp (0.74%), Renaissance Technologies LLC (0.61%), Fiera Capital Corp (0.59%) and AlpInvest Partners B.V. (0.23%). Company insiders that own Natera stock include Herm Rosenman, James Healy, Jonathan Sheena, Matthew Rabinowitz and Roelof Botha.

Who sold Natera stock? Who is selling Natera stock?

Natera's stock was sold by a variety of institutional investors in the last quarter, including Discovery Group I LLC, Franklin Resources Inc. and Wall Street Associates. Company insiders that have sold Natera stock in the last year include Herm Rosenman, Jonathan Sheena and Matthew Rabinowitz.

Who bought Natera stock? Who is buying Natera stock?

Natera's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, A.R.T. Advisors LLC, Boothbay Fund Management LLC, Russell Investments Group Ltd., State Street Corp and GSA Capital Partners LLP. Company insiders that have bought Natera stock in the last two years include James Healy and Roelof Botha.

How do I buy Natera stock?

Shares of Natera can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Natera stock cost?

One share of Natera stock can currently be purchased for approximately $9.78.

Natera (NASDAQ:NTRA) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Earnings History Chart

Earnings by Quarter for Natera (NASDAQ:NTRA)

Dividend History Chart

Dividend Payments by Quarter for Natera (NASDAQ:NTRA)

Last Updated on 2/22/2017 by Staff